A Study of Decreased Dose Frequency in Participants With Systemic Juvenile Arthritis Who Experience Laboratory Abnormalities During Treatment With RoActemra/Actemra (Tocilizumab)
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Tocilizumab
Related studies linked through entity extraction aliases.
Pilot Study of Tocilizumab in Patients With Erdheim-Chester Disease
- Status
- TERMINATED
- Phase
- PHASE2
Musculoskeletal Ultrasound in Predicting Early Dose Titration With Tocilizumab
- Status
- COMPLETED
- Phase
- PHASE4
Study of the Safety, Tolerability, and Bioactivity of Tocilizumab On Patients With Non-infectious UVEITIS: The STOP-UVEITIS Study
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
A Long-term Safety Extension Study of Tocilizumab in Brazilian Participants With Rheumatoid Arthritis (RA) Who Completed the Studies ML21530 and MA21488
- Status
- COMPLETED
- Phase
- PHASE4
A Non-Interventional Study of Rheumatoid Arthritis Patients Treated With RoActemra/Actemra (Tocilizumab) in Monotherapy
- Status
- COMPLETED
- Phase
- N/A
An Open-Label Trial of Tocilizumab in Schizophrenia
- Status
- COMPLETED
- Phase
- PHASE1
Tocilizumab for the Treatment of Behcet's Syndrome
- Status
- TERMINATED
- Phase
- PHASE2
A Non-Interventional Study of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- N/A
A Long Term Extension Study of WA19926 (NCT01007435) of Tocilizumab (RoActemra/Actemra) in Participants With Early, Moderate to Severe Rheumatoid Arthritis (RA)
- Status
- COMPLETED
- Phase
- PHASE3
A Long-Term Extension Study to WA19926 (NCT01007435) of Tocilizumab in Participants With Early, Moderate to Severe Rheumatoid Arthritis
- Status
- TERMINATED
- Phase
- PHASE3
An Extension Study of WA19926 of the Long-Term Safety of Tocilizumab (RoActemra/Actemra) in Patients With Early Moderate to Severe Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Evaluate Tocilizumab Treatment in a Real-Life Setting
- Status
- COMPLETED
- Phase
- N/A
A Long-Term Extension Study of WA22762 and NA25220 of Subcutaneous (SC) Tocilizumab (TCZ) in Moderate to Severe Rheumatoid Arthritis (RA)
- Status
- COMPLETED
- Phase
- PHASE3
A Study of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate in Patients With Severe Active Rheumatoid Arthritis, Comparing Tapering Versus Maintaining the Methotrexate Dosage
- Status
- TERMINATED
- Phase
- PHASE4
A Long-Term Extension Study of WA19926 on the Safety of Tocilizumab (RoActemra/Actemra) in Participants With Early Moderate to Severe Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Tocilizumab in Participants With Active Rheumatoid Arthritis (RA) and an Inadequate Response to Non-Biological Disease-modifying Anti-rheumatic Drugs (DMARDs)
- Status
- COMPLETED
- Phase
- N/A
Tocilizumab in the Management of Juvenile Idiopathic Arthritis Associated Uveitis
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Safety Study of Tocilizumab to Improve Transplant Rates in Highly Sensitized Patients Awaiting Kidney Transplantation
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Observational Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- N/A